Cargando…
Abnormal Sodium is a Predictor for Respiratory Failure and Mortality in Hospitalized Patients With COVID-19
Background: Hypernatremia and hyponatremia (serum sodium > 145 mmol/L and < 135 mmol/L, respectively) are independent risk factors for excess mortality in patients with bacterial pneumonia. We sought, for the first time, an association of sodium [Na] abnormalities with mortality, need for adva...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135456/ http://dx.doi.org/10.1210/jendso/bvab048.1269 |
_version_ | 1783695344670867456 |
---|---|
author | Tzoulis, Ploutarchos Waung, Julian Bagkeris, Emmanouil Hussein, Ziad Biddanda, Aiyappa Cousins, John Dewsnip, Alice Falayi, Kanoyin McCaughran, P W Mullins, Chloe Naeem, Ammara Nwokolo, Munachiso Quah, Helen Bitat, Syed Rabha Deyab, Eithar Ponnampalam, Swarupini Bouloux, Pierre-Marc Gilles Montgomery, Hugh Baldeweg, Stephanie |
author_facet | Tzoulis, Ploutarchos Waung, Julian Bagkeris, Emmanouil Hussein, Ziad Biddanda, Aiyappa Cousins, John Dewsnip, Alice Falayi, Kanoyin McCaughran, P W Mullins, Chloe Naeem, Ammara Nwokolo, Munachiso Quah, Helen Bitat, Syed Rabha Deyab, Eithar Ponnampalam, Swarupini Bouloux, Pierre-Marc Gilles Montgomery, Hugh Baldeweg, Stephanie |
author_sort | Tzoulis, Ploutarchos |
collection | PubMed |
description | Background: Hypernatremia and hyponatremia (serum sodium > 145 mmol/L and < 135 mmol/L, respectively) are independent risk factors for excess mortality in patients with bacterial pneumonia. We sought, for the first time, an association of sodium [Na] abnormalities with mortality, need for advanced respiratory support and Acute Kidney Injury (AKI) in hospitalized patients with coronavirus disease 19 (COVID-19). Methods: This retrospective, longitudinal, cohort study included 488 adults, 277 males and 211 females, with a median age of 68 years, who were hospitalized with COVID-19 to two hospitals in London over an 8-week period (February to May 2020). Results: The in-hospital mortality rate was 31.1% with a medial length of stay of 8 days. High [Na] levels at any timepoint during hospital stay were associated with significantly increased mortality rate (56.6% vs 21.1% in patients who remained constantly normonatremic; odds ratio 3.05, 95% CI 1.69-5.49; p<0.0001). On day 3 and on day 6, high [Na] values predicted mortality with an estimated odds ratio of 2.34 (95% CI 1.08 – 5.05, p=0.0014) and 2.40 (95% CI 1.18 - 4.85, p=0.001), respectively. Non-survivors had a significantly higher 5-day rise in serum [Na] when compared to survivors (3.60 mmol/L vs 1.14 mmol/L respectively, p<0.05). Patients with low serum [Na] levels on admission had a 2.18-fold increase (95% CI 1.34-3.46, p=0.001) in the likelihood of needing advanced ventilatory support compared to those with normal [Na] (31.7% vs 17.5%, respectively). However, exposure to hyponatremia at any timepoint, including at presentation or on day 3 or day 5, was not associated with excess risk of death. AKI affected 37.1% of patients (21.3%, 7.4% and 8.4% stages 1, 2 and 3 respectively) but was not related to serum sodium values. Conclusions: In hospitalized COVD-19 patients, hypernatremia at any timepoint was associated with excess mortality, suggesting that [Na] concentration may facilitate risk stratification. In addition, whilst our data cannot prove causality, these findings highlight the significance of judicious rehydration in such patients. |
format | Online Article Text |
id | pubmed-8135456 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-81354562021-05-21 Abnormal Sodium is a Predictor for Respiratory Failure and Mortality in Hospitalized Patients With COVID-19 Tzoulis, Ploutarchos Waung, Julian Bagkeris, Emmanouil Hussein, Ziad Biddanda, Aiyappa Cousins, John Dewsnip, Alice Falayi, Kanoyin McCaughran, P W Mullins, Chloe Naeem, Ammara Nwokolo, Munachiso Quah, Helen Bitat, Syed Rabha Deyab, Eithar Ponnampalam, Swarupini Bouloux, Pierre-Marc Gilles Montgomery, Hugh Baldeweg, Stephanie J Endocr Soc Neuroendocrinology and Pituitary Background: Hypernatremia and hyponatremia (serum sodium > 145 mmol/L and < 135 mmol/L, respectively) are independent risk factors for excess mortality in patients with bacterial pneumonia. We sought, for the first time, an association of sodium [Na] abnormalities with mortality, need for advanced respiratory support and Acute Kidney Injury (AKI) in hospitalized patients with coronavirus disease 19 (COVID-19). Methods: This retrospective, longitudinal, cohort study included 488 adults, 277 males and 211 females, with a median age of 68 years, who were hospitalized with COVID-19 to two hospitals in London over an 8-week period (February to May 2020). Results: The in-hospital mortality rate was 31.1% with a medial length of stay of 8 days. High [Na] levels at any timepoint during hospital stay were associated with significantly increased mortality rate (56.6% vs 21.1% in patients who remained constantly normonatremic; odds ratio 3.05, 95% CI 1.69-5.49; p<0.0001). On day 3 and on day 6, high [Na] values predicted mortality with an estimated odds ratio of 2.34 (95% CI 1.08 – 5.05, p=0.0014) and 2.40 (95% CI 1.18 - 4.85, p=0.001), respectively. Non-survivors had a significantly higher 5-day rise in serum [Na] when compared to survivors (3.60 mmol/L vs 1.14 mmol/L respectively, p<0.05). Patients with low serum [Na] levels on admission had a 2.18-fold increase (95% CI 1.34-3.46, p=0.001) in the likelihood of needing advanced ventilatory support compared to those with normal [Na] (31.7% vs 17.5%, respectively). However, exposure to hyponatremia at any timepoint, including at presentation or on day 3 or day 5, was not associated with excess risk of death. AKI affected 37.1% of patients (21.3%, 7.4% and 8.4% stages 1, 2 and 3 respectively) but was not related to serum sodium values. Conclusions: In hospitalized COVD-19 patients, hypernatremia at any timepoint was associated with excess mortality, suggesting that [Na] concentration may facilitate risk stratification. In addition, whilst our data cannot prove causality, these findings highlight the significance of judicious rehydration in such patients. Oxford University Press 2021-05-03 /pmc/articles/PMC8135456/ http://dx.doi.org/10.1210/jendso/bvab048.1269 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Neuroendocrinology and Pituitary Tzoulis, Ploutarchos Waung, Julian Bagkeris, Emmanouil Hussein, Ziad Biddanda, Aiyappa Cousins, John Dewsnip, Alice Falayi, Kanoyin McCaughran, P W Mullins, Chloe Naeem, Ammara Nwokolo, Munachiso Quah, Helen Bitat, Syed Rabha Deyab, Eithar Ponnampalam, Swarupini Bouloux, Pierre-Marc Gilles Montgomery, Hugh Baldeweg, Stephanie Abnormal Sodium is a Predictor for Respiratory Failure and Mortality in Hospitalized Patients With COVID-19 |
title | Abnormal Sodium is a Predictor for Respiratory Failure and Mortality in Hospitalized Patients With COVID-19 |
title_full | Abnormal Sodium is a Predictor for Respiratory Failure and Mortality in Hospitalized Patients With COVID-19 |
title_fullStr | Abnormal Sodium is a Predictor for Respiratory Failure and Mortality in Hospitalized Patients With COVID-19 |
title_full_unstemmed | Abnormal Sodium is a Predictor for Respiratory Failure and Mortality in Hospitalized Patients With COVID-19 |
title_short | Abnormal Sodium is a Predictor for Respiratory Failure and Mortality in Hospitalized Patients With COVID-19 |
title_sort | abnormal sodium is a predictor for respiratory failure and mortality in hospitalized patients with covid-19 |
topic | Neuroendocrinology and Pituitary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135456/ http://dx.doi.org/10.1210/jendso/bvab048.1269 |
work_keys_str_mv | AT tzoulisploutarchos abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT waungjulian abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT bagkerisemmanouil abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT husseinziad abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT biddandaaiyappa abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT cousinsjohn abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT dewsnipalice abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT falayikanoyin abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT mccaughranpw abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT mullinschloe abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT naeemammara abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT nwokolomunachiso abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT quahhelen abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT bitatsyedrabha abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT deyabeithar abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT ponnampalamswarupini abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT boulouxpierremarcgilles abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT montgomeryhugh abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 AT baldewegstephanie abnormalsodiumisapredictorforrespiratoryfailureandmortalityinhospitalizedpatientswithcovid19 |